Positions

Overview

  • Dr. Marrazzo is Professor of Medicine and Director of the Division of Infectious Diseases at the University of Alabama at Birmingham. She is internationally recognized for her research and education efforts in the field of sexually transmitted infections, especially as they affect women’s health. She is a Fellow of the American College of Physicians and of the Infectious Diseases Society of America. Dr. Marrazzo has chaired the American Board of Internal Medicine (ABIM) Council, and the ABIM Infectious Disease Specialty Board. She is board certified in Infectious Disease.
    She conducts research on the human microbiome, specifically as it relates to female reproductive tract infections and hormonal contraception. Her other research interests include prevention of HIV infection using biomedical interventions, including PrEP and microbicides. Other research interests include pathogenesis and management of bacterial vaginosis, sexually transmitted diseases in HIV-infected persons, and management of antibiotic resistance in gonorrhea.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2018 PrEParing Women to Prevent HIV: An Integrated Theoretical Framework to PrEP Black Women in the United States.Journal of the Association of Nurses in AIDS Care.  29:835-848. 2018
    2018 Sexually Transmitted Infection Prevalence in Women With HIV: Is There a Role for Targeted Screening?Sexually Transmitted Diseases.  45:762-769. 2018
    2018 Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial.Clinical Infectious Diseases2018
    2018 Health Care Provider Perceptions of a Sexually Transmitted Infection Self-testing Program in an HIV Care Clinic.Sexually Transmitted Diseases.  45:417-421. 2018
    2018 BIOMEDICAL PREVENTION OF HIV IN WOMEN: CHALLENGES AND APPROACHES, WITH PARTICULAR REFERENCE TO THE VAGINAL MICROBIOME.Transactions- American Clinical and Climatological Association.  129:63-73. 2018
    2018 Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvement.PLoS Medicine.  15:e1002485. 2018
    2017 Diversity in the US Infectious Diseases Workforce: Challenges for Women and Underrepresented Minorities.Journal of Infectious Diseases.  216:S606-S610. 2017
    2017 The fourth generation AlereTM HIV Combo rapid test improves detection of acute infection in MTN-003 (VOICE) samples.Journal of Clinical Virology.  94:15-21. 2017
    2017 HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights.AIDS Research and Human Retroviruses.  33:749-759. 2017
    2017 Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial.Journal of Women's Health.  26:670-676. 2017
    2017 Prevention of Sexually Transmitted Diseases in HIV-Infected Individuals.Current HIV/AIDS Reports.  14:41-46. 2017
    2017 Clinical performance of the Solana® Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women.Expert Review of Molecular Diagnostics.  17:303-306. 2017
    2017 Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations.AIDS Research and Human Retroviruses2017
    2017 Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003).Sexually Transmitted Diseases.  44:135-140. 2017
    2017 Sexually transmitted infections: challenges ahead.Lancet Infectious Diseases.  17:e235-e279. 2017
    2016 A conversation among the IAS–USA board of directors: Hot topics and emerging data in HIV research and careTopics in antiviral medicine.  24:142-151. 2016
    2016 HIV Prevention: Opportunities and Challenges.Topics in antiviral medicine.  24:123-126. 2016
    2016 HIV prevention: Opportunities and challengesTopics in antiviral medicine.  24:123-126. 2016
    2016 Ocular Syphilis: a Clinical ReviewCurrent Infectious Disease Reports.  18. 2016
    2016 Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?AIDS and Behavior.  20:2654-2661. 2016
    2016 Validity of self-reported history of Chlamydia trachomatis infection.American Journal of Obstetrics and Gynecology.  216:393.e1-393.e7. 2016
    2016 More Easily Cultivated Than Identified: Classical Isolation With Molecular Identification of Vaginal Bacteria.Journal of Infectious Diseases.  214 Suppl 1:S21-S28. 2016
    2016 The Vaginal Microbiome: Current Understanding and Future Directions.Journal of Infectious Diseases.  214 Suppl 1:S36-S41. 2016
    2016 Variations in Clinical Presentation of Ocular Syphilis: Case Series Reported From a Growing Epidemic in the United States.Sexually Transmitted Diseases.  43:519-523. 2016
    2016 An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women.Journal of Acquired Immune Deficiency Syndromes.  72:333-343. 2016
    2016 Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection.Medical Clinics of North America.  100:927-950. 2016
    2016 Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay.Sexually Transmitted Diseases.  43:369-373. 2016
    2016 Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis.Journal of Acquired Immune Deficiency Syndromes.  71:287-294. 2016
    2016 Pharmacological Measures of Treatment Adherence and Risk of HIV Infection in the VOICE Study.Journal of Infectious Diseases.  213:335-342. 2016
    2016 Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study.Journal of the International AIDS Society.  19:20642. 2016
    2015 Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial.Journal of Infectious Diseases.  212:1949-1956. 2015
    2015 A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds.AIDS Research and Human Retroviruses.  31:1055-1059. 2015
    2015 Disclosure of pharmacokinetic drug results to understand nonadherence.AIDS.  29:2161-2171. 2015
    2015 Barriers to Bacterial Sexually Transmitted Infection Testing of HIV-Infected Men Who Have Sex With Men Engaged in HIV Primary Care.Sexually Transmitted Diseases.  42:590-594. 2015
    2015 Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.American Journal of Reproductive Immunology.  74:313-322. 2015
    2015 Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women.American Journal of Reproductive Immunology.  74:323-332. 2015
    2015 Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk - Authors' reply.Lancet HIV.  2:e366-e367. 2015
    2015 Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial Vaginosis.Journal of Infectious Diseases.  212:793-802. 2015
    2015 Relationship of Specific Bacteria in the Cervical and Vaginal Microbiotas With Cervicitis.Sexually Transmitted Diseases.  42:475-481. 2015
    2015 Syphilis? An Unusual Cause of Surgical Emergency in a Human Immunodeficiency Virus-Infected Man.Open Forum Infectious Diseases.  2:ofv094. 2015
    2015 Advancing Care for Lesbian, Gay, Bisexual, and Transgender Persons: Enough Already?Annals of Internal Medicine.  163:143-144. 2015
    2015 A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis.Sexually Transmitted Diseases.  42:376-381. 2015
    2015 Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.Lancet HIV.  2:e279-e287. 2015
    2015 Women Who Have Sex with Women Living in Low- and Middle-Income Countries: A Systematic Review of Sexual Health and Risk Behaviors.LGBT Health.  2:91-104. 2015
    2015 Perceptions and Experiences with the VOICE Adherence Strengthening Program (VASP) in the MTN-003 Trial.AIDS and Behavior.  19:770-783. 2015
    2015 Metabolic signatures of bacterial vaginosis.mBio.  6. 2015
    2015 Tenofovir-based preexposure prophylaxis for HIV infection among African women.New England Journal of Medicine.  372:509-518. 2015
    2015 Factors associated with bone mineral density in healthy African women.Archives of Osteoporosis.  10:206. 2015
    2015 Tenofovir-based preexposure prophylaxis for HIV infection among African womenObstetrical and Gynecological Survey.  70:444-446. 2015
    2014 What's new in sexually transmitted infections in the HIV care setting: focus on syphilis and gonorrhea.Topics in antiviral medicine.  22:698-701. 2014
    2014 ACP Journal Club. Review: Self-collected samples are less accurate for HPV testing than clinician-collected samples.Annals of Internal Medicine.  161:JC11. 2014
    2014 Changes in Vaginal Bacterial Concentrations with Intravaginal Metronidazole Therapy for Bacterial Vaginosis as Assessed by Quantitative PCR.Journal of Clinical Microbiology.  52:3137-3137. 2014
    2014 HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.Journal of the American Medical Association.  312:390-409. 2014
    2014 Bacterial vaginosis and the cervicovaginal immune response.American Journal of Reproductive Immunology.  71:555-563. 2014
    2014 Antiviral activity of genital tract secretions after oral or topical tenofovir pre-exposure prophylaxis for HIV-1.Journal of Acquired Immune Deficiency Syndromes.  66:65-73. 2014
    2014 Addressing standards of care in resource-limited settings.Journal of Acquired Immune Deficiency Syndromes.  65 Suppl 1:S10-S14. 2014
    2014 Improving HIV/STD prevention in the care of persons living with HIV through a national training program.AIDS patient care.  28:15-21. 2014
    2014 Recent advances in understanding and managing Chlamydia trachomatis infections.F1000prime reports.  6:120. 2014
    2013 Bacterial vaginosis-associated bacteria in men: association of Leptotrichia/Sneathia spp. with nongonococcal urethritis.Sexually Transmitted Diseases.  40:944-949. 2013
    2013 Introduction to the special issue highlighting Anaerobe 2012.Anaerobe.  24:85-86. 2013
    2013 Screening and management of genital chlamydial infections.Infectious Disease Clinics of North America.  27:739-753. 2013
    2013 Sexually transmitted infections. Preface.Infectious Disease Clinics of North America.  27:ix-x. 2013
    2013 A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.Sexually Transmitted Diseases.  40:499-505. 2013
    2013 Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae.Journal of Clinical Microbiology.  51:1666-1672. 2013
    2013 Vaginal biofilms and bacterial vaginosis: of mice and women.Journal of Infectious Diseases.  207:1481-1483. 2013
    2013 American Sexually Transmitted Diseases Association and the Thomas Parran Award: past, present, and future.Sexually Transmitted Diseases.  40:275-276. 2013
    2013 Editorial commentary: Sexual networks, sex hormones, and recurrent bacterial vaginosis: not such strange bedfellows.Clinical Infectious Diseases.  56:787-789. 2013
    2013 More than meets the eye: associations of vaginal bacteria with gram stain morphotypes using molecular phylogenetic analysis.PLoS ONE.  8:e78633. 2013
    2013 Population-level benefits from providing effective HIV prevention means to pregnant women in high prevalence settings.PLoS ONE.  8:e73770. 2013
    2012 Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial.Journal of Infectious Diseases.  206:1931-1935. 2012
    2012 Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis.Journal of Infectious Diseases.  205:1580-1588. 2012
    2012 The posttrial effect of oral periodic presumptive treatment for vaginal infections on the incidence of bacterial vaginosis and Lactobacillus colonization.Sexually Transmitted Diseases.  39:361-365. 2012
    2012 Emerging Sexual Health Issues Among Women Who Have Sex with Women.Current Infectious Disease Reports2012
    2012 Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria.PLoS ONE.  7:e37818. 2012
    2012 Behavioral predictors of colonization with Lactobacillus crispatus or Lactobacillus jensenii after treatment for bacterial vaginosis: a cohort study.Infectious Diseases in Obstetrics & Gynecology.  2012:706540. 2012
    2012 Chlamydia positivity in women screened in family planning clinics: Racial/ethnic differences and trends in the Northwest U.S., 1997-2006Public Health Reports.  127:38-51. 2012
    2011 Effect of sexual activity on vaginal colonization with hydrogen peroxide-producing lactobacilli and Gardnerella vaginalis.Sexually Transmitted Diseases.  38:1137-1144. 2011
    2011 Interventions to prevent sexually transmitted infections, including HIV infection.Clinical Infectious Diseases.  53 Suppl 3:S64-S78. 2011
    2011 Sexually transmitted infections among women who have sex with women.Clinical Infectious Diseases.  53 Suppl 3:S84-S91. 2011
    2011 A behavioural intervention to reduce persistence of bacterial vaginosis among women who report sex with women: results of a randomised trial.Sexually Transmitted Infections.  87:399-405. 2011
    2011 Interpreting the epidemiology and natural history of bacterial vaginosis: are we still confused?Anaerobe.  17:186-190. 2011
    2011 Establishing and sustaining a healthy vaginal environment: analysis of data from a randomized trial of periodic presumptive treatment for vaginal infections.Journal of Infectious Diseases.  204:323-326. 2011
    2011 Chlamydia trachomatis infection among women reporting sexual activity with women screened in Family Planning Clinics in the Pacific Northwest, 1997 to 2005.American Journal of Public Health.  101:1284-1290. 2011
    2011 Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.PLoS ONE.  6:e23136. 2011
    2010 Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID.Sexually Transmitted Diseases.  37:732-744. 2010
    2010 Antiretroviral-based HIV prevention strategies for women.Expert Review of Anti-infective Therapy.  8:1177-1186. 2010
    2010 Even NHANES evolves: Some surprising findings about women who have sex with women.Sexually Transmitted Diseases.  37:414-415. 2010
    2010 Risks for acquisition of bacterial vaginosis among women who report sex with women: a cohort study.PLoS ONE.  5:e11139. 2010
    2010 Prevalence and risks for bacterial vaginosis in women who have sex with women.Sexually Transmitted Diseases.  37:335-339. 2010
    2010 Walter E. Stamm, MD, 1945-2009.Sexually Transmitted Diseases.  37:281-282. 2010
    2010 Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis.PLoS ONE.  5:e10197. 2010
    2009 Preferred characteristics of vaginal microbicides in women with bacterial vaginosis.Journal of Women's Health.  18:1163-1167. 2009
    2009 Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR.Journal of Clinical Microbiology.  47:721-726. 2009
    2009 Distribution of genital Lactobacillus strains shared by female sex partners.Journal of Infectious Diseases.  199:680-683. 2009
    2009 Sexually transmitted infections and associated conditions among women who have sex with womenOpen Infectious Diseases Journal.  3:128-134. 2009
    2008 Acceptability of urine-based screening for Chlamydia trachomatis in asymptomatic young men: a systematic review.Sexually Transmitted Diseases.  35:S28-S33. 2008
    2008 The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature.Sexually Transmitted Diseases.  35:S51-S60. 2008
    2008 The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.Sexually Transmitted Diseases.  35:S66-S75. 2008
    2008 Chlamydia positivity in American Indian/Alaska Native women screened in family planning clinics, 1997-2004.Sexually Transmitted Diseases.  35:753-757. 2008
    2008 Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis.Applied and Environmental Microbiology.  74:4898-4909. 2008
    2008 Routine HIV testing in the context of syndromic management of sexually transmitted infections: outcomes of the first phase of a training programme in Botswana.Sexually Transmitted Infections.  84:259-264. 2008
    2008 Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women.Annals of Internal Medicine.  149:20-28. 2008
    2008 Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis.Sexually Transmitted Infections.  84:57-61. 2008
    2007 Emerging issues in management of sexually transmitted diseases in HIV infection.Current Infectious Disease Reports.  9:518-530. 2007
    2007 Population-based outreach for Chlamydia screening in men: results from a randomized trial.Sexually Transmitted Diseases.  34:837-839. 2007
    2007 Elusive aetiology of bacterial vaginosis. Do lesbians have a clue?Sexually Transmitted Infections.  83:424-425. 2007
    2007 Expanding the spectrum of pathogens in urethritis: implications for presumptive therapy?Clinical Infectious Diseases.  45:872-874. 2007
    2007 Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis.Journal of Clinical Microbiology.  45:3270-3276. 2007
    2007 Within the hidden epidemic: sexually transmitted diseases and HIV/AIDS among American Indians and Alaska Natives.Sexually Transmitted Diseases.  34:767-777. 2007
    2007 Selective testing criteria for gonorrhea among young women screened for Chlamydial infection: contribution of race and geographic prevalence.Journal of Infectious Diseases.  196:731-737. 2007
    2007 Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial.Obstetrics and Gynecology.  110:302-309. 2007
    2007 Management of women with cervicitis.Clinical Infectious Diseases.  44 Suppl 3:S102-S110. 2007
    2007 Acceptability of urine-based screening for Chlamydia trachomatis to asymptomatic young men and their providers.Sexually Transmitted Diseases.  34:147-153. 2007
    2007 Superficial hepatic capsular lesions in a systemically ill young woman.Sexually Transmitted Diseases.  34:139-140. 2007
    2007 Syphilis and other sexually transmitted diseases in HIV infection.Topics in HIV Medicine.  15:11-16. 2007
    2007 Correlates of sexually transmitted infections in young women.Journal of Infectious Diseases.  195:303. 2007
    2006 Reply to Forney et al. [4]Journal of Infectious Diseases.  194:1469-1470. 2006
    2006 Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis.Journal of Women's Health.  15:1053-1060. 2006
    2006 A persistent(ly) enigmatic ecological mystery: bacterial vaginosis.Journal of Infectious Diseases.  193:1475-1477. 2006
    2006 Prevalence of Neisseria Gonorrhoeae among men screened for Chlamydia Trachomatis in four United States cities, 1999-2003.Sexually Transmitted Diseases.  33:314-319. 2006
    2006 Risk factors for cervicitis among women with bacterial vaginosis.Journal of Infectious Diseases.  193:617-624. 2006
    2006 Chlamydial infections among female adolescents screened in juvenile detention centers in Washington State, 1998-2002.Sexually Transmitted Diseases.  33:63-67. 2006
    2006 Bacteria associated with bacterial vaginosis.New England Journal of Medicine.  354:202-203. 2006
    2005 Molecular identification of bacteria associated with bacterial vaginosis.New England Journal of Medicine.  353:1899-1911. 2005
    2005 Molecular methodology in determining vaginal flora in health and disease: its time has come.Current Infectious Disease Reports.  7:463-470. 2005
    2005 Cervical specimen order and performance measures of Chlamydia trachomatis diagnostic testing.Journal of Clinical Microbiology.  43:5295-5297. 2005
    2005 Dangerous assumptions: lesbians and sexual death.Sexually Transmitted Diseases.  32:570-571. 2005
    2005 Mucopurulent cervicitis: no longer ignored, but still misunderstood.Infectious Disease Clinics of North America.  19:333-viii. 2005
    2005 Sexual practices, risk perception and knowledge of sexually transmitted disease risk among lesbian and bisexual women.Family Planning Perspectives.  37:6-12. 2005
    2005 Sexual tourism: implications for travelers and the destination culture.Infectious Disease Clinics of North America.  19:103-120. 2005
    2005 Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for detection of Chlamydia trachomatis in women with genital infections.Journal of Clinical Microbiology.  43:577-584. 2005
    2005 Prevalence of Chlamydia trachomatis infection among men screened in 4 U.S. cities.Sexually Transmitted Diseases.  32:74-77. 2005
    2004 Evolving issues in understanding and treating bacterial vaginosis.Expert Review of Anti-infective Therapy.  2:913-922. 2004
    2004 Barriers to infectious disease care among lesbians.Emerging Infectious Diseases.  10:1974-1978. 2004
    2004 Re-evaluating selective screening criteria for chlamydial infection among women in the U S Pacific Northwest.Sexually Transmitted Diseases.  31:283-289. 2004
    2004 Reproductive health history of lesbians: implications for care.American Journal of Obstetrics and Gynecology.  190:1298-1304. 2004
    2004 Sexually transmitted diseases in the HIV care setting: what's really going on down there?Topics in HIV Medicine.  12:57-60. 2004
    2004 Lesbian Health Matters: A Pap Test Education Campaign Nearly Thwarted by DiscriminationHealth Promotion Practice.  5:314-325. 2004
    2003 Prevalence and risk factors for infection with herpes simplex virus type-1 and -2 among lesbians.Sexually Transmitted Diseases.  30:890-895. 2003
    2003 Functional characterization of class Ia- and non-class Ia-restricted Chlamydia-reactive CD8+ T cell responses in humans.Journal of Immunology.  171:4278-4286. 2003
    2003 Candidiasis (vulvovaginal).Clinical Evidence -London-.  1980-1993. 2003
    2003 Vulvovaginal candidiasis.BMJ.  326:993-994. 2003
    2003 Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: a systematic review.Obstetrical and Gynecological Survey.  58:351-358. 2003
    2003 The clinical and economic consequences of screening young men for genital chlamydial infection.Sexually Transmitted Diseases.  30:99-106. 2003
    2003 Chlamydia trachomatis infection in asymptomatic men.American Journal of Preventive Medicine.  24:36-42. 2003
    2002 Head-to-head multicenter comparison of DNA probe and nucleic acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard.Journal of Clinical Microbiology.  40:3757-3763. 2002
    2002 Extracts from "Concise Clinical Evidence": Vulvovaginal candidiasisBMJ.  325:586. 2002
    2002 Vulvovaginal candidiasis.BMJ.  325:586. 2002
    2002 Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis.Obstetrics and Gynecology.  100:579-584. 2002
    2002 Vulvovaginal candidiasis.Clinical Evidence -London-.  1784-1796. 2002
    2002 Characterization of vaginal flora and bacterial vaginosis in women who have sex with women.Journal of Infectious Diseases.  185:1307-1313. 2002
    2001 Erratum: The relative increase in prevalence using LCR was highest among men with < 5 polymorphonuclear leukocytes per high-power (1000×) field (PMN/HPF) on urethral Gram stain regardless of symptoms, and in symptomatic men with gonorrhea diagnosed by urethral culture (Sexually Transmitted Diseases 28:4 (220))Sexually Transmitted Diseases.  28:429. 2001
    2001 Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women.American Journal of Public Health.  91:947-952. 2001
    2001 Impact of New Sexually Transmitted Disease Diagnostics on Clinical Practice and Public Health Policy.Current Infectious Disease Reports.  3:147-151. 2001
    2001 Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics.Sexually Transmitted Diseases.  28:219-225. 2001
    2001 Characteristics of female sexually transmitted disease clinic clients who report same-sex behaviour.International Journal of STD and AIDS.  12:41-46. 2001
    2000 Sexually transmitted infections in women who have sex with women: who cares?Sexually Transmitted Infections.  76:330-332. 2000
    2000 Genital human papillomavirus infection in women who have sex with women: a review.American Journal of Obstetrics and Gynecology.  183:770-774. 2000
    2000 Genital human papillomavirus infection in women who have sex with women: a concern for patients and providers.AIDS patient care.  14:447-451. 2000
    1998 Genital human papillomavirus infection in women who have sex with women.Journal of Infectious Diseases.  178:1604-1609. 1998
    1998 New approaches to the diagnosis, treatment, and prevention of chlamydial infection.Current Clinical Topics in Infectious Diseases.  18:37-59. 1998
    1997 Selective screening for chlamydial infection in women: a comparison of three sets of criteriaFamily Planning Perspectives.  29:158-162. 1997
    1997 Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay.Annals of Internal Medicine.  127:796-803. 1997
    1997 Selective screening for chlamydial infection in women: a comparison of three sets of criteria.Family Planning Perspectives.  29:158-162. 1997
    1997 Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy.Sexually Transmitted Diseases.  24:131-141. 1997
    1997 Cesarean delivery in women with genital herpes in washington state, 1989-1991.Infectious Diseases in Obstetrics & Gynecology.  5:29-35. 1997
    1995 Chancroid: new developments in an old disease.Current Clinical Topics in Infectious Diseases.  15:129-152. 1995
    A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care.Topics in antiviral medicine.  24:142-151.
    Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea.New England Journal of Medicine.  379:1835-1845.

    Chapter

    Year Title Altmetric
    2014 Neisseria gonorrhoeae (Gonorrhea).  2446-2462.e3. 2014
    2013 Bacterial Vaginosis.  463-498. 2013
    2013 Syphilis in Women.  461-471. 2013
    2013 Topical Microbicides for Human Immunodeficiency Virus and Sexually Transmitted Disease Prevention.  213-227. 2013
    2013 Chlamydia trachomatis infection among sexual minorities.  142-150. 2013
    2013 Enhancing women's sexual health: Prevention measures in diverse populations of women.  197-219. 2013
    2012 Bacterial Vaginosis.  54-63. 2012
    2011 Introduction to Sexually Transmitted Infections.  300-302. 2011
    2001 Chlamydiae.  795-822. 2001

    Research Overview

  • Effects of contraceptive ring on vaginal microbiota, HIV shedding and local immunity
    Optimizing Vaginal Ring Pre-Exposure Prophylaxis for HIV
    The Genital Microbiome as a Determinant of Sexual Health & Local Immunity
    The Role of Uncultivated Bacteria in Bacterial Vaginosis
    Vaginal and oral pre-exposure prophylaxis to prevent HIV and HSV-2 infection in women
  • Teaching Overview

  • Dr. Marrazzo lectures on topics related to vaginal health and sexually transmitted infections.
  • Education And Training

  • Bachelor of Arts in Biology, Harvard University
  • Doctor of Medicine, Thomas Jefferson University
  • Master of Public Health in Epidemiology, University of Washington
  • Yale-New Haven Hospital, Internship 1989
  • Yale-New Haven Hospital, Residency 1991
  • University of Washington, Postdoctoral Fellowship 1995
  • Full Name

  • Jeanne Marrazzo